VAERS Explorer
Back to explore

Report #2883700

Received Feb 2, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
OH
Recovered
Unknown
Vaccinated
Dec 16, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1946907—

Symptoms (1)

Product storage error

Symptom narrative

Administered to an Employee, Vaccine Administered Without Temperature Monitoring for 3 Days; Initial report received on 18-Dec-2025. A reporter in the reported that a patient (age and gender not available) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization that had been stored in a refrigerator with no temperature monitoring for 3 days. No medical history or concomitant medications were reported. On 16-Dec-2025, the patient received a dose of a hepatitis B vaccine [HEPLISAV-B (lot number 946907; expiration date, NDC number, and site not available)]. The HEPLISAV-B administered had been stored in a refrigerator with no temperature monitoring for 3 days. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.